Ovid Therapeutics
Price & Volume
Stats
See more52W Range | $0.24-$3.42 |
Market Cap | $24.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $566,000 |
Revenue Growth (YoY) | -46.5% |
Gross Profit (12 Mos) | $566,000 |
Diluted EPS | -$0.37 |
News
See moreYahoo Finance • 2 months ago
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
Yahoo Finance • 2 months ago
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Yahoo Finance • 3 months ago
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Yahoo Finance • last year
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
About
CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
Address | 441 Ninth Avenue, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
